# Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion

> **NCT03998709** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Somatostatin
- **OTHER:** Dextrose
- **DRUG:** Insulin
- **OTHER:** Intralipid

## Key facts

- **NCT ID:** NCT03998709
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** results from other study suggest no good reason to proceed
- **Last updated:** 2022-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998709, "Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03998709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*